Earlier this week Aiforia Technologies launched the Aiforia Community Platform — one of the only available platforms of this nature, for pathologists and scientists utilizing AI for image analysis software in preclinical and clinical...

Aiforia Technologies Plc announces the CE-IVD marking of the Aiforia® Clinical AI Model for Breast Cancer; ER. Adding to its repertoire of CE-IVD marked clinical AI models for cancer diagnostics, the new AI model automates the calculation of...

See AI in action from Aiforia at USCAP! We have a lot to offer this year! You can either attend our Monday seminar, join our evening event, explore our posters, or visit us at booth #315! Monday seminar Yukako Yagi PhD Director of...

Aiforia and Genuv will collaborate to integrate Aiforia’s deep learning AI into Genuv’s ATRIVIEW® discovery platform for neurodegenerative diseases. The two companies announced an agreement to add Aiforia’s artificial...

Leveraging each other’s expertise in digital pathology and deep learning AI, Mayo Clinic and Aiforia aim to enable faster results and scalable studies in translational research. January 12, 2022 -- Aiforia, a technology company providing...

Aiforia has announced its latest virtual workshop. Practical applications of AI from research to clinical practice November 8th 12pm to 3pm EST (Boston) Join our free virtual workshop to hear from speakers at Memorial Sloan Kettering Cancer...